Changes in Bone Markers May Predict Fracture Reduction With Anti-resorptive Drug


eMediNexus    19 January 2018

A meta-regression analysis of 14 clinical trials, published online in the Journal of Bone and Mineral Research, suggests that treatment-related changes in bone formation markers predict vertebral-fracture reduction with anti-resorptive drug therapy. Drugs that prevent and treat osteoporosis are known to cause short-term changes in bone-turnover markers, and these changes have been linked to subsequent fracture reduction in some studies. The results from this analysis could pave way for the development of new osteoporosis treatments or when considering new populations or dosing regimens with existing treatment.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.